Morgan Keegan Maintains Outperform on Health Care REIT (HCN)

Morgan Keegan is out with its report today on Health Care REIT HCN, maintaining Outperform. In a note to clients, Morgan Keegan writes, "We believe that Health Care REIT can sustain 4%-5% FFO growth long-term through internal growth, accretive acquisitions, and facility development. Our investment thesis calls for accretive new investments driving higher earnings, yielding a higher share price absent multiple expansion. We maintain our Outperform rating." Shares of HCN closed Monday at $52.41, up 0.21% from Friday's close.